Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Rising Prices and Americans’ Focus on Value Keeps Consumer Technology Revenue Growth on a Moderate Track Through 2028, Reports Circana
-
Inside information: Siili Solutions Plc lowers its financial guidance for 2026 revenue and adjusted EBITA
-
Appian Announces Second Quarter 2026 Financial Results
-
Lifetime Brands, Inc. Reports Second Quarter 2026 Financial Results
-
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
-
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
-
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
-
Inventus Reports Up to 75% Gold Recovery from Heap Leach Testwork at Pardo
-
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
-
Getty Copper Inc. Begins Trading on OTCQX Best Market
-
KVH Industries Reports Second Quarter 2026 Results
-
Purpose Investments Launches ETF Series of Canada's First Structured Equity Yield Fund (TSX: PSY)
-
Arianne Phosphate Selected to Benefit from the Québec Government’s Specialized Filon Support Service
-
Lee Enterprises Reports Strong Third Quarter Results and Increases 2026 Fiscal Year Outlook
-
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
-
Peloton Announces Q4 & FY2026 Financial Results
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
-
Capital City Bank Earns 15th Consecutive “Best Companies” Honor, Ranks in Top 10
-
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
-
Ligand Reports Second Quarter 2026 Financial Results
-
illumin Reports Second Quarter 2026 Financial Results
-
Gilat Demonstrates Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links
-
Macerich Announces Proposed Offering of Exchangeable Senior Notes
-
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
-
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
-
Peloton Announces Q4 & FY2026 Financial Results
-
Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
-
GPGI Reports Second Quarter 2026 Results
-
Safe Pro Group Receives $780,000 Purchase Order for Department of War Package of Edge AI-Powered Threat Mapping and Blue UAS Drones
-
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
-
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
-
Gogo Announces Second Quarter Results
-
Commerce Announces Second Quarter 2026 Financial Results
-
CareCloud Reports Second Quarter 2026 Results
-
Ongwe Minerals Provides Update on Its Newly Discovered Nguni Prospect, Namibia
-
Kobo Resources Expands Gold Mineralisation Across Multiple Structures at the Road Cut Zone Ahead of Inaugural MRE
-
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
-
Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialization of medtech portfolio
-
GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update
-
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
-
Rogers Sugar Delivers Robust Third Quarter Results, Driven by Solid Sugar Segment Performance
-
Aya Gold & Silver Acquires Strategic Exploration Portfolio in Morocco
-
Rogers Sugar Inc. Declares Dividend to Shareholders
-
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
-
Deep Isolation Nuclear, Inc. Reports Operational and Financial Results for the Second Quarter of 2026
